Search Results
584 items found for "GPCR therapeutics"
- The Gluopsins: Opsins without the Retinal Binding Lysine
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Newsletter HERE
- 📰 GPCR Weekly News, May 22 to 28, 2023
Hi GPCR lovers👋, Ready for exciting news in the GPCR world? Read them below! GPCR Activation and Signaling The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain relief. Patients with Idiopathic Pulmonary Fibrosis Exscientia Business Update for First Quarter 2023 Structure Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, November 6 to November 12, 2023
This week, we've curated 12 GPCR papers. GPCR Symposium for the year, which will focus on GPCRs in Immunology and Oncology. for high-throughput gpcrs antibody discovery Reviews, GPCRs, and more Current strategic trends in drug Target for Therapeutic Development in Gastrointestinal Diseases Sosei Heptares Operational Highlights GPCR Ecosystem
- 📰 GPCR Weekly News, May 15 to 21, 2023
Hi GPCR buffs 👋! This week's GPCR papers feature a publication from Dr. Marta Filizola. GPCR Symposium on GPCR Activation and Signaling was a great success. GPCR Activation and Signaling Monitoring the Reversibility of GPCR Signaling by Combining Photochromic Hopkins, Exscientia’s founder and CEO was elected a Fellow of the Academy of Medical Sciences Structure Therapeutics GPCR Ecosystem
- Molecular insights into regulation of constitutive activity by RNA editing 5HT2C serotonin receptor
network located on intracellular loop 2 that is subject to RNA editing, which differentially affects GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Good day, GPCR folks! Take advantage of our GPCR highlights of the week. Dr. GPCR Symposium for the year on GPCRs in Immunology and Oncology! , and more RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic for Daridorexant (ACT-541468), a Dual Orexin Receptor Antagonist for the Treatment of Insomnia OMass Therapeutics Releases First Protein Structures in PDB, Advances Lupus Therapy Research Structure Therapeutics Receives
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
August 2022 RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. GPCRs are involved in a variety of physiological and pathophysiological processes. So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and manifestations, highlighting a potential new area for therapeutic intervention. Read more at the source #DrGPCR #GPCR #IndustryNews
- Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024
Greetings, Pioneers of GPCR Science! Receptors for New Therapeutic Options 📍 Boston, MA 📅 October 2 -3, 2024 Join leading scientists to News MBX aims for $136M IPO to take potential rival to Ascendis' Yorvipath into phase 3 Certa Therapeutics proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and
- 📰 GPCR Weekly News, May 8 to 14, 2023
2 Epilepsy Clinical Study’s Independent Interim Review Committee Recommends Continuing Study Addex Therapeutics Research Council (ERC) Addex Reports Q1 2023 Financial Results And Provides Corporate Update Structure Therapeutics Reports First Quarter 2023 Financial Results and Recent Highlights OMass Therapeutics presented at the BioEquity Conference British Patient Capital Invests £10m in next-generation drug development company OMass Therapeutics American Society for Pharmacology and Experimental Therapeutics (May 18 - 21, 2023).
- PI(4,5)P 2-stimulated positive feedback drives the recruitment of Dishevelled to Frizzled in Wnt-β-c
that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 24 to 30, 2023
Greetings fellow GPCR enthusiasts! This week's GPCR papers feature publications from Drs. Thomas P. Check out some of the latest GPCR discoveries below! GPCR Symposium on GPCR Activation and Signaling on May 19th, 2023. Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics GPCR Ecosystem
- Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84
August 2022 "Despite the importance of members of the GPCR superfamily as targets of a broad range of effective medicines many GPCRs remain poorly characterised. pharmacological tool compounds to study its broader role and biology. " Read more at the source #DrGPCR #GPCR
- 📰 GPCR Weekly News, April 17 to 23, 2023
GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. GPCRs in Neuroscience G protein coupled receptors as targets for transformative neuropsychiatric therapeutics GPCRs in Oncology and Immunology CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment Inversago Pharma will present at BBHIC 2023 Orion Biotechnology attended the Swiss Biotech Day Addex Therapeutics GPCR Events, Meetings, and Webinars ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
October 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance Although many cardiovascular GPCRs have been extensively studied as model receptors for decades, new As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation nanobodies with tailored specificities may expand the impact of these tools for both basic science and therapeutic Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 10 to 16, 2023
GPCR Symposium on GPCR Activation and Signaling on May 19th, 2023. Discovery Summit, Boston MA Pathios Therapeutics Unveils PTT-4256, a Highly Potent and Selective Inhibitor Michel Bouvier received the title of Doctor Honoris Causa from the Université de Montpellier Domain Therapeutics presented 3 posters at AACR 2023 Exscientia presented a poster at AACR 2023 Pathios Therapeutics presented Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Notably, G-protein-coupled receptors (GPCRs), representing the biggest drug target, have been revealed Historically, drug discovery efforts targeting GPCRs focused on G-protein-dependent signaling pathways therapeutics. Minireview: targeting GPCR activated ERK pathways for drug discovery. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells, 10(10), 2509.
- 📰 GPCR Weekly News, September 25 to October 1, 2023
GPCR Symposia? GPCR Newsletter! of traditional Chinese medicine in the treatment of glioblastoma multiforme Industry News Structure Therapeutics Half-Year Financial Results and Exciting Developments at Aelis Farma Ion Channel Drug Developer Maxion Therapeutics Lefkowitz's Career at Duke October 3, 2023, | FREE Seminar: Changing paradigm on Therapeutics targeting
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs ) that act in an allosteric manner to modulate the activity of GPCRs. activity in an orthosteric site-independent manner to compounds with therapeutic potential that have development for each receptor, as well as the structural, signaling, pathophysiologic consequences, and therapeutic Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 3 to 9, 2023
GPCR Symposium on GPCR Activation and Signaling held on May 19th, 2023. GPCRs in Neuroscience G protein-coupled receptors (GPCRs) as Potential Therapeutics for Psychiatric Disorders Domain Therapeutics to present three posters at AACR 2023 annual meeting. Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology and Experimental Therapeutics GPCR Ecosystem
- 📰 GPCR Weekly News, March 20 to 26, 2023
GPCR Ecosystem. Industry News Domain Therapeutics was one of the 4 Biotech Trophy nominees at 2023 HealthTech awards. Function Therapeutics has been awarded a Phase 1 SBIR grant from NSF. Function Therapeutics has a new website. Call for GPCR Papers GPCRs: Signal Transduction. GPCR Ecosystem
- Phosphorylation of RGS regulates MAP kinase localization and promotes completion of cytokinesis
Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' Showcase your project with a 1-minute abstract video Bolsters Leadership Team as the Company Advances its Multi-Product Pipeline Toward Clinical Studies Confo Therapeutics 21st Annual Global Healthcare Conference CEO Raymond Stevens to Speak at STAT Future Summit on Obesity Therapeutics Call for GPCR Papers NEW opnMe GPCR Route 66+ project. Function and Biased Signaling" at the DOT NEW October 3, 2023 | FREE Seminar: Changing paradigm on Therapeutics
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
release of these hormones in the adrenals is tightly regulated by adrenal G protein-coupled receptors (GPCRs In this review, we discuss important aspects of adrenal GPCR signaling and regulation, as they pertain modulation of cardiac function in the context of chronic HF, by focusing on the 2 best studied adrenal GPCR the β-arrestins in the adrenals, 2 protein families that regulate the signaling and functioning of GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P 2 Lipids
lipids have been shown to stabilize an active conformation of class A G-protein coupled receptors (GPCRs ) through a conserved binding site, not present in class B GPCRs. with the Glucagon receptor (GCGR), which constitutes an important target for diabetes and obesity therapeutics conformation of GCGR through a binding site conserved across class B GPCRs but absent in class A GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Grab your flux capacitors, GPCR time travelers! GPCR University 🎥 Recorded GPCR Courses and Symposia / Summit 💲 Special Pricing on GPCR courses GPCR community members Join the GPCR fan club and geek out with fellows! So much more to come! How Structural Biology Informs the Development of Drugs Targeting G Protein-Coupled Receptors ARTICA THERAPEUTICS Jobs NEW GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCR Symposium event held on March 24th? GPCR Activation and Signaling Autoregulation of GPCR signalling through the third intracellular loop. Domain Therapeutics was nominated for the Trophée de l'Innovation Technologique (Technological Innovation Papers GPCRs: Signal Transduction. GPCR Ecosystem
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
Greetings, GPCR Colleague! Prepare to be amazed! Shocking GPCR revelations await you. GPCR University 🎥 Recorded GPCR Courses and Symposia / Summit 💲 Special Pricing on GPCR courses GPCR community members Connect with fellow GPCR enthusiasts :) So much more to come! Pathios Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GPR65 Inhibitor Jobs NEW Scientist - Biology Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Hoist the sails, GPCR sailors! GPCR, the journey is just beginning! GPCR courses GPCR Forum Start an engaging discussion or request help in your research. GPCR community members Build connections with other GPCR fans :) So much more to come! Jobs Scientist I Cell Biology - Tectonic Therapeutic Senior Principal Scientist, Medicinal Chemistry